Your browser doesn't support javascript.
Monoclonal Antibody and Antiviral Therapy for Mild-to-Moderate COVID-19 in Pediatric Patients.
Vora, Surabhi B; Englund, Janet A; Trehan, Indi; Waghmare, Alpana; Kong, Ada; Adler, Amanda; Zerr, Danielle M.
  • Vora SB; From the Department of Pediatrics, University of Washington, Seattle, Washington.
  • Englund JA; From the Department of Pediatrics, University of Washington, Seattle, Washington.
  • Trehan I; From the Department of Pediatrics, University of Washington, Seattle, Washington.
  • Waghmare A; From the Department of Pediatrics, University of Washington, Seattle, Washington.
  • Kong A; Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington.
  • Adler A; Division of Infectious Diseases, Seattle Children's Hospital, Seattle, Washington.
  • Zerr DM; From the Department of Pediatrics, University of Washington, Seattle, Washington.
Pediatr Infect Dis J ; 42(1): 32-34, 2023 01 01.
Article in English | MEDLINE | ID: covidwho-2246108
ABSTRACT
Multiple antiviral and monoclonal antibody therapies are now available for mild-moderate COVID-19 in high-risk patients ≥12 years of age. However, data for the use of these agents in children is limited. We reviewed 94 pediatric patients for whom early therapy was requested since the emergence of the Omicron variant and describe patient characteristics, treatment logistics and associated short-term events.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Antibodies, Monoclonal Type of study: Prognostic study Topics: Variants Limits: Child / Humans Language: English Journal: Pediatr Infect Dis J Journal subject: Communicable Diseases / Pediatrics Year: 2023 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Antibodies, Monoclonal Type of study: Prognostic study Topics: Variants Limits: Child / Humans Language: English Journal: Pediatr Infect Dis J Journal subject: Communicable Diseases / Pediatrics Year: 2023 Document Type: Article